Transforming growth factor β signaling overcomes dasatinib resistance in lung cancer. [electronic resource]
Producer: 20150928Description: e114131 p. digitalISSN:- 1932-6203
- Aniline Compounds -- metabolism
- Antineoplastic Agents -- metabolism
- Antineoplastic Combined Chemotherapy Protocols
- Apoptosis -- drug effects
- Carcinoma, Non-Small-Cell Lung -- pathology
- Cell Line, Tumor
- Dasatinib
- Drug Resistance, Neoplasm
- Humans
- Intracellular Space -- drug effects
- Lung Neoplasms -- pathology
- Molecular Docking Simulation
- Nitriles -- metabolism
- Protein Conformation
- Protein Serine-Threonine Kinases -- chemistry
- Pyrimidines -- metabolism
- Quinolines -- metabolism
- Receptor, Transforming Growth Factor-beta Type I
- Receptors, Transforming Growth Factor beta -- chemistry
- Signal Transduction -- drug effects
- Smad3 Protein -- metabolism
- Thiazoles -- metabolism
- Transforming Growth Factor beta -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.